Gwyneth Paltrow & Huberman Evaluate GLP-1 Drug Retratrutide: Pros & Cons

On May 20, 2026

Understanding Retatrutide: A New Development in GLP-1 Therapies

Introduction to GLP-1 Therapies and Retatrutide

If you’re interested in the latest advancements in GLP-1 (glucagon-like peptide-1), you’ll find Retatrutide particularly fascinating. Gwyneth Paltrow, the health and wellness enthusiast, recently discussed this new therapy with neuroscientist Dr. Andrew Huberman on her podcast.

GLP-1 Therapies and Weight Loss

GLP-1 receptor agonists have been a hot topic in discussions about biohacking, longevity, and wellness in recent years. However, these therapies are not devoid of side effects. Huberman pointed out that the first-generation weight-loss drugs decreased users’ appetites, resulting in rapid, severe caloric deficits.

The Role of Retatrutide in Weight Loss

Retatrutide is a new development in this area. This triple agonist activates the body’s receptors for glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1), and glucagon. These three hormones play critical roles in regulating blood sugar, appetite, and metabolism. In clinical trials, Retatrutide is administered as a once-weekly subcutaneous injection.

The Potential Benefits of Retatrutide

Huberman explains that due to its balanced, multi-receptor approach, Retatrutide has a “lower side effect profile”. It allows individuals to lose up to a third of their body weight over a year. Another significant aspect is that Retatrutide appears to have a “muscle sparing effect,” which is critical for fitness and longevity enthusiasts.

Caution About Online Purchasing

It’s important to exercise caution with Retatrutide, especially as it is currently moving through official pipelines. A vast gray market of compounding pharmacies and online peptide suppliers has emerged to meet the growing demand. Huberman warns against these unregulated sources, as they may contain bacterial toxins, known as lipopolysaccharides, that can cause inflammation.

Final Thoughts on Retatrutide and GLP-1 Therapies

Retatrutide is currently an investigational molecule that is legally available only to participants in Lilly’s clinical trials. According to the manufacturer’s website, the company is currently “evaluating its safety and efficacy.” It’s crucial to prioritize working with a medical doctor and avoid unverified online sources if you’re exploring these therapies.